Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company has shown steady growth in sales of bio-fermented feed, with significant improvement in cash flow [1] - The revenue for 2024 is projected to be 2.78 billion yuan, a decrease of 20.92% year-on-year, while the net profit attributable to shareholders is expected to be -565.5 million yuan, a decline of 309.69% [7] - The company is focusing on expanding its bio-fermented feed business, which accounted for 78% of total revenue in 2024, while actively reducing its environmental engineering business [7] Financial Summary - Total revenue is forecasted to increase from 2.78 billion yuan in 2024 to 8.12 billion yuan in 2027, with a compound annual growth rate (CAGR) of 38.08% [1][8] - The net profit attributable to shareholders is expected to recover from -565.5 million yuan in 2024 to 740 million yuan in 2027, reflecting a significant turnaround [1][8] - The earnings per share (EPS) is projected to improve from -0.56 yuan in 2024 to 0.74 yuan in 2027 [1][8] Business Performance - The bio-fermented feed segment generated revenue of 2.17 billion yuan in 2024, representing a year-on-year increase of 10.19% [7] - The company plans to increase its production capacity for bio-fermented feed to 700,000 tons per year by the end of 2024, with 470,000 tons already operational [7] - The sales volume of bio-fermented feed is expected to reach 112,600 tons in 2024, a growth of 20.75% year-on-year [7] Cash Flow and Financial Health - The operating cash flow is projected to significantly increase to 53 million yuan in 2024, a rise of 379.41% [7] - The company has actively pursued the collection of historical receivables, recovering 49.53 million yuan from accounts aged over two years [7] - The total assets are expected to grow from 1.725 billion yuan in 2024 to 1.952 billion yuan in 2027 [8]

丨证券研究报告丨 公司研究丨点评报告丨路德环境（688156.SH） [Table_Title] 路德环境 2024&2025Q1 业绩点评：生物发酵饲 料产能持续释放，价格下调拖累业绩提升 报告要点 [Table_Summary] 路德环境 2024 年实现营业收入 2.78 亿元，同比下降 20.92%，归母净利润亏损 0.57 亿元，去 年同期为盈利 0.27 亿元；2025 年 Q1 实现收入 0.63 亿元，同比下滑 7.18%，归母净利润 0.01 亿元，同比下滑 77.89%。2024 年白酒糟生物发酵饲料业务实现产品销量 11.26 万吨，同比增 长 20.74%，实现销售收入 2.17 亿元，同比增长 10.19%，收入占比达 78.11%。公司已披露的 生物发酵饲料规划产能合计达 70 万吨/年，其中已投产项目 47 万吨/年，其中遵义、亳州、永 乐项目合计 30 万吨/年产能 2024 年 Q4 新投产，期待产能爬坡打开未来业绩成长空间。 分析师及联系人 [Table_Author] 徐科 任楠 贾少波 李博文 盛意 SAC：S0490517090001 SAC：S04905180700 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The report highlights steady growth in sales of bio-fermented feed and significant improvement in cash flow [1] - The company is focusing on expanding its bio-fermented feed business, which now accounts for 78% of its revenue, while actively reducing its environmental engineering business [7] - The report anticipates a gradual increase in production capacity, with a projected annual capacity of 700,000 tons for bio-fermented feed by the end of 2024 [7] Financial Summary - Total revenue for 2024 is projected at 2.78 billion yuan, a decrease of 20.92% year-on-year, with a net profit attributable to shareholders of -0.57 billion yuan, down 309.69% [7] - The gross margin for the bio-fermented feed segment is expected to be 21.93%, reflecting a decrease of 14.32 percentage points [7] - The company’s operating cash flow is expected to increase significantly, with a net operating cash flow of 0.53 billion yuan in 2024, up 379.41% [7] - The report forecasts a net profit of 0.17 billion yuan for 2025 and 0.35 billion yuan for 2026, with a long-term net profit projection of 0.74 billion yuan for 2027 [1][8] Business Performance - The revenue from the distiller's grains feed segment is projected to be 2.17 billion yuan in 2024, representing a year-on-year increase of 10.19% [7] - The company’s sales volume for distiller's grains bio-fermented feed is expected to reach 11.26 million tons in 2024, an increase of 20.75% [7] - The average selling price for this segment is projected to be 1,926 yuan per ton, down 8.74% year-on-year [7] Market Data - The closing price of the company's stock is 14.39 yuan, with a market capitalization of 1,449.28 million yuan [5] - The price-to-earnings ratio (P/E) is projected to be 89.85 for 2025 and 44.11 for 2026 [1][8] Asset and Liability Overview - The company’s total assets are projected to be 1,725 million yuan in 2024, with total liabilities of 853 million yuan [8] - The debt-to-asset ratio is expected to be 49.41% in 2024, indicating a moderate level of leverage [8] Future Outlook - The report emphasizes the strategic importance of the company's bio-fermented feed products in ensuring food security, as they can partially replace soybean meal and corn [7] - The company is positioned as an industry leader with expanding production capacity, which is expected to enhance long-term profitability [1][7]

Group 1 - The company reported a revenue of 278 million yuan for the year 2024, representing a year-on-year decrease of 20.92% [1] - The net profit attributable to shareholders was -56.55 million yuan, a decline of 309.69% compared to the previous year's profit of 26.97 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -59.67 million yuan, down 391.6% from the previous year's 20.46 million yuan [1] - The net cash flow from operating activities was 53.45 million yuan, compared to -19.13 million yuan in the previous year [1] Group 2 - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 22, 2020, with an issuance of 22.96 million shares at a price of 15.91 yuan per share [1] - The total amount raised from the initial public offering (IPO) was 365 million yuan, with a net amount of 324 million yuan after deducting issuance costs [1] - The final net amount raised was 25.83 million yuan less than the original plan of 350 million yuan [1] Group 3 - The company incurred issuance costs of 41.12 million yuan for its IPO, including underwriting fees of 29.22 million yuan [2] - In 2022, the company raised funds through a private placement, issuing 8.34 million shares at a price of 13.57 yuan per share, totaling 113.18 million yuan [2] - After deducting non-tax issuance costs of 4.15 million yuan, the actual net amount raised was 109.03 million yuan [2] - The total funds raised from the IPO and the 2022 private placement amounted to 47.8 million yuan [3]

路德生物环保科技股份有限公司 证券代码：688156 证券简称：路德环境 公告编号：2025-015 路德生物环保科技股份有限公司 关于作废 2020 年限制性股票激励计划部分已授予 尚未归属的限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 路德生物环保科技股份有限公司（以下简称"公司"）于2025年4月17日召开第四届董 事会第二十三次会议、第四届监事会第十九次会议，审议通过了《关于作废2020年限制性股 票激励计划部分已授予尚未归属的限制性股票的议案》，根据公司《2020年限制性股票激励 计划（草案修订稿）》（以下简称"《激励计划》"）、《2020年限制性股票激励计划实施 考核管理办法（修订稿）》（以下简称"《考核管理办法》"）的规定和公司2020年第二次 临时股东大会的授权，公司董事会同意作废2020年限制性股票激励计划（以下简称"本次激 励计划"）部分已授予但尚未归属的限制性股票共115,800股。现将有关事项说明如下： 一、本次激励计划已履行的决策程序和信息披露情况 （一）2020 年 11 月 ...

泰和泰 (武汉)律师事务所 关于路德环境科技股份有限公司2023年限制性 股票激励计划部分已授予尚未归属的限制性股 2023年限制性股票激励计划部分已授予尚未归属的限 制性股票作废相关事项 之 FIRM LAW 法律意见书 泰和泰律師事務所 TAHOTA LAW FIRM 泰和泰(武汉)律师事务所 关于 路德环境科技股份有限公司 票作废相关事项之 成都·Chengdu|北京·Beijing|深圳·Shenzhen|香港·HongKong|重庆·Chongqing| 拉萨 · Lhasa|上海 · Shanghai|昆明·Kunming| 济南·Jinan|贵阳·Guiyang|南京· nanjing| 天津 tianjin|西安 · Xian|武汉 · Wuhan|太原·Taiyuan|西宁· Xining|海口·Haikou| 华盛顿·Washington|首尔·Seoul|尼泊尔·Nepal|悉尼·Sydey|曼谷·Bangkok 关于路德环境科技股份有限公司 2023年限制性股票激励计划部分已授予尚未归属的限制性 股票作废相关事项之 法律意见书 致:路德生物环保科技股份有限公司 泰和泰(武汉)律师事务所 ...

路德生物环保科技股份有限公司 内控审计报告 大信审字[2025]第 2-00517 号 大信会计师事务所（特殊普通合伙） WUYIGE CERTIFIED PUBLIC ACCOUNTANTS LLP. 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ac.mof.gov.cn】 th 移 1 号 22 = 2206 WUYIGE Certified Public Accountants Room2206 22/F,Xueyuan International Tower No.1 ZhichunRoad,Haidian Dist. Beijing,China,100083 www.daxincpa.com.cn 内部控制审计报告 大信审字[2025]第 2-00517 号 路德生物环保科技股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我们审计了路 德生物环保科技股份有限公司（以下简称"贵公司"）2024年 12 月 31 日的财务报告内部控制 的有效性。 一、企业对内部控制的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发 ...

国投证券股份有限公司 关于路德生物环保科技股份有限公司 2024 年度募集资金存放与实际使用情况的核查意见 国投证券股份有限公司（以下简称"国投证券"或"保荐机构"，曾用名为安信 证券股份有限公司）作为路德生物环保科技股份有限公司（简称"路德环境"或"公 司"）的保荐机构和持续督导机构，根据《上市公司监管指引第 2 号——上市公司 募集资金管理和使用的监管要求》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》《上海证券交易所科创板股票上市规则》等相关规定，对路德 环境 2024 年度募集资金年度存放与实际使用情况进行了审慎核查，具体情况如 下： 一、募集资金基本情况 （一）扣除发行费用后的实际募集资金金额、资金到账时间 1、2020 年首次公开发行股票实际募集资金情况 经中国证券监督管理委员会《关于同意路德生物环保科技股份有限公司首次 公开发行股票注册的批复》（证监许可[2020]1915 号）核准，并经上海证券交易 所同意，公司首次向社会公开发行人民币普通股股票 2,296 万股，发行价格为每 股 15.91 元，募集资金总额为 36,529.36 万元，根据相关规定扣除发行费用 4,111.8 ...